Table 3 HBV, HCV and HIV distribution in gender of acute leukemia cases
Laboratory results | Gender | Â | ||
|---|---|---|---|---|
Male | Female | Total | P value* | |
Count (%) | Count (%) | Count (%) | ||
Total HBV (HBsAg pos and HBV-DNA pos) | 25(22.9) | 13(19) | 38(21.6) | 0.580 |
HBsAg pos | 9(8.3) | 10(14.9) | 19(10.8) | 0.166 |
HBsAg neg, Anti-HBcAg pos and HBV-DNA pos | 16(14.8) | 3(4.5) | 19(10.8) | 0.034 |
HBsAg neg, Anti-HBcAg pos and HBV-DNA neg | 10(9.2) | 11(16.4) | 21(11.9) | 0.150 |
Ag and Anti-HIV pos | 0(0) | 3(4.5) | 3(1.7) | 0.026 |
Anti-HCV pos | 3(2.8) | 0(0) | 3(1.7) | 0.171 |